2007The Journal of Clinical PsychiatryRequires access

Comparative analysis between ziprasidone and risperidone in treatment of schizophrenia

Chen Ke-qua

Open publisher page 1 citations

Abstract

Objective:To explore the efficacy and safety of ziprasidone in treatment of schizophrenia.Method:80 patients with schizophrenia were randomly assigned to two groups,ziprasidone group(n=40)and resperidone group(n=40)for 8 weeks.Positive and negative syndrome scale(PANSS)and treatment emergent side effect scale(TESS)were used to evaluate the efficacy and side effects respectively.Results:The response rate and marked response rate in patients of ziprasidone group were 65.0% and 85.0% after 8 weeks,similar to risperidone group.Both the total PANSS scores and factor scores decreased significantly after treatment in two groups(67.5% and 87.5%).However,there were no significant differences between two groups.Total incidence of side effects in ziprasidone group was significantly lower than that in risperidone group.Conclusion:Ziprasidone has a better efficacy in treatment of schizophrenia,which is as effective as resperidone and has fewer side effects compared with risperidone.

About this research paper

What this paper is about

Objective:To explore the efficacy and safety of ziprasidone in treatment of schizophrenia.Method:80 patients with schizophrenia were randomly assigned to two groups,ziprasidone group(n=40)and resperidone group(n=40)for 8 weeks.Positive and negative syndrome scale(PANSS)and treatment emergent side effect scale(TESS)were used to evaluate the efficacy and side effects respectively.Results:The response rate and marked response rate in patients of ziprasidone group were 65.0% and 85.0% after 8 weeks,similar to risperidone group.Both the total PANSS scores and factor scores decreased significantly after treatment in two groups(67.5% and 87.5%).However,there were no significant differences between two groups.Total incidence of side effects in ziprasidone group was significantly lower than that in risperidone group.Conclusion:Ziprasidone has a better efficacy in treatment of schizophrenia,which is as effective as resperidone and has fewer side effects compared with risperidone.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore the efficacy and safety of ziprasidone in treatment of schizophrenia.Method:80 patients with schizophrenia were randomly assigned to two groups,ziprasidone group(n=40)and resperidone group(n=40)for 8 weeks.Positive and negative syndrome scale(PANSS)and treatment emergent side effect scale(TESS)were used to evaluate the efficacy and side effects respectively.Results:The response rate and marked response rate in patients of ziprasidone group were 65.0% and 85.0% after 8 weeks,similar to risperidone group.Both the total PANSS scores and factor scores decreased significantly after treatment in two groups(67.5% and 87.5%).However,there were no significant differences between two groups.Total incidence of side effects in ziprasidone group was significantly lower than that in risperidone group.Conclusion:Ziprasidone has a better efficacy in treatment of schizophrenia,which is as effective as resperidone and has fewer side effects compared with risperidone.

Key concepts: Ziprasidone, Risperidone, Positive and Negative Syndrome Scale, Schizophrenia (object-oriented programming), Internal medicine, Psychology, Side effect (computer science), Negative symptom

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparative analysis between ziprasidone and risperidone in treatment of schizophrenia — Research Paper | ScholarLens